Boyd Mudenda
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 6
- Cancer-related Molecular Pathways 2
- Cancer Immunotherapy and Biomarkers 2
-
- Advanced Breast Cancer Therapies 2
- Co-authors
- Lindsay B. Robertson (2 shared papers)Sam Leinster (2 shared papers)Charles Michelo (3 shared papers)Aditya Bardia (3 shared papers)David M. Goldenberg (3 shared papers)Robert M. Sharkey (3 shared papers)William A. Wegener (3 shared papers)Pius Maliakal (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Research (5 papers)European Journal of Cancer (1 paper)Journal of Public Health (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesZambiaUnited Kingdom
In The Last Decade
Boyd Mudenda
20 papers receiving 439 citations
Peers
Comparison fields: 5 of 53
- Oncology 242
- Radiology, Nuclear Medicine and Imaging 81
- Family Practice 6
- Biotechnology 28
- Cancer Research 43
Countries citing papers authored by Boyd Mudenda
This map shows the geographic impact of Boyd Mudenda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyd Mudenda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyd Mudenda more than expected).
Fields of papers citing papers by Boyd Mudenda
This network shows the impact of papers produced by Boyd Mudenda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyd Mudenda. The network helps show where Boyd Mudenda may publish in the future.
Co-authors
The 25 scholars most cited alongside Boyd Mudenda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 147 | |
| 2 | 1994 | 81 | |
| 3 | 2009 | 38 | |
| 4 | 2015 | 36 | |
| 5 | 1994 | 29 | |
| 6 | 2018 | 18 | |
| 7 | 2021 | 16 | |
| 8 | 2017 | 15 | |
| 9 | 2014 | 15 | |
| 10 | 2017 | 13 | |
| 11 | 2017 | 9 | |
| 12 | 2017 | 5 | |
| 13 | 2009 | 5 | |
| 14 | 2008 | 5 | |
| 15 | DETERMINATION OF OXYTETRACYCLINE RESIDUE LEVELS IN EDIBLE TISSUES OF SLAUGHTERED CATTLE | 2018 | 4 |
| 16 | 2020 | 4 | |
| 17 | 2016 | 4 | |
| 18 | 2010 | 1 | |
| 19 | 2009 | 1 | |
| 20 | 2010 | 1 |
About Boyd Mudenda
Boyd Mudenda is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Epidemiology, having authored 21 papers that have together received 447 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (4 papers), Advanced Breast Cancer Therapies (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Diabetes Management and Education (2 papers), Multiple and Secondary Primary Cancers (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Oncology (242 citations), Radiology, Nuclear Medicine and Imaging (81 citations), Family Practice (6 citations), Biotechnology (28 citations) and Cancer Research (43 citations). Boyd Mudenda has collaborated with scholars based in United States, Zambia and United Kingdom. Frequent co-authors include Lindsay B. Robertson, Sam Leinster, Charles Michelo, Aditya Bardia, David M. Goldenberg, Robert M. Sharkey, William A. Wegener, Pius Maliakal, Michael J. Guarino and Gregory A. Masters. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, European Journal of Cancer, Journal of Public Health and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.